Facebook FanPage Exclusive- Nutrition – Video

28-01-2012 19:59 NUTRITION...NUTRITION...NUTRITION guys and gals. That's what's probably missing out of your equitation to your success. Check out http://www.acfitbody.com for more about fitness, nutrition, supplements and more! TEAM Optimum Nutrition IFBB PRO Physique Athlete Follow me on Twitter! twitter.com http://www.alexcarneiro.com

See the original post here:
Facebook FanPage Exclusive- Nutrition - Video

Multitalented Detroiter loves being Telly Monster in ‘ Sesame Street Live’

More Photos

Click thumbnails to enlarge

Telly (rear) is played by Angelo Williams.

Angelo Williams as Telly Monster, appearing in "Sesame Street Live: Elmo’s Super Heroes" at the Fisher Theatre.

Former Detroiter Angelo Williams is touring with the company of "Elmo's Super Heroes" as Telly Monster.

Former Detroiter Angelo Williams has a degree in biochemistry; maybe as many stamps in his passport as Hillary Clinton; and a fuzzy purple alter ego.

Williams, 28, who graduated from Detroit’s High School of Arts, plays Telly Monster, one of the eponymous superheroes of “Sesame Street Live – Elmo’s Super Heroes.”

An “Army brat” born in Nuremberg, Germany, Williams was already well travelled before hitting Motown, Main Street and, finally, touring with Sesame Street. After graduating from high school, Williams did a year at Wayne State University before heading south to dance at Disney World in shows such as the Magic Kingdom’s Main Street Trolley Show and The Festival of the Lion King at Disney’s Animal Kingdom.

He credits a lot of water and Gatorade with his survival. “It’s a lot of hard work, especially in the summer when it’s 98 degrees when you’re in a button-up shirt and vest,” Williams said.

While in Orlando, Fla., he had a visit from a friend and fellow dancer from the Freedom Dance Expressions Company, who was touring with "Dragon Tales Live." Like "Sesame Street Live," it was produced by the VEE Corp. He spent time with the "Dragon Tales" company while they were performing in Orlando, and was invited to audition.

He began his first tour with "Sesame Street Live" in 2005, as Big Bird in “Super Grover Ready for Action,” the original version of the recently updated “Elmo’s Super Heroes.”

Williams has toured with each of the three touring casts of "Sesame Street Live" for the last seven years, playing both Big Bird and Telly, who was Williams’ favorite as a kid.

“He’s very quirky and he’s very spastic, too. He can be very upbeat and then be down a little,” said Williams.

The three casts tour the East Coast, the West Coast and the theater circuit with different shows, and each has international stops. Williams said his most interesting stop was Singapore. The company spent New Year’s Eve in Mexico City, where the soundtrack for the show is in Spanish.

He says that Sesame Street is every bit as beloved around the world as it is here at home. Continued...

“The show offers so much for all ages,” said Williams, whose favorite song in the current show is a take on “One” from “A Chorus Line.” “It’s like we’re in a Broadway show.”

Between tours, Williams earned a dual degree in dance education and biochemistry from the University of Central Florida. His residence is in Newark, Del.

He likes to read, and do gymnastics and has participated on competition cheer teams. The last book he read was the final Harry Potter book, which he saved for after seeing the movie, because he didn’t want to be disappointed. This way, Williams’ reasons, “The book just totally fills in the blanks.”

Asked if he’s interested in the movie business, Williams laughed. "Not unless I hit the lottery.”

Williams has a 6-year-old nephew and a niece on the way. His nephew has seen “every show I’ve been in since he was born. I’m the cool uncle.”

The next move for the multitalented Williams “is to figure out a longterm goal.” He says he is “getting ready for family mode” now, and would like to either open a dance studio and teach or put his biochemistry degree to work in research, where he’s leaning toward pharmaceuticals.

But his most immediate plan is to hustle off to Buffalo for another opening and another show of "Sesame Street Live."

See the rest here:
Multitalented Detroiter loves being Telly Monster in ' Sesame Street Live'

New Governance Structure Approved by AMP Membership

Newswise — BETHESDA, MD, February 6, 2012 – The members of the Association for Molecular Pathology voted in favor of adopting significant changes to the structure of its governing body. The changes resulted in two primary refinements; 1) a shift from management by a Council to management by a Board of Directors and an Executive Committee, and 2) the transition of Subdivision Chairs from the role of Annual Meeting programming to one that focuses directly on the interests and needs of the subdivision discipline.

The shift from the Council model to a Board and Executive Committee structure allows the Board to continually appraise the Association at a high level and to develop long-range goals, plans, and policies, thus allowing the Executive Committee to focus on operational issues including the implementation of the strategy, direction, and policies established by the Board. The overall strategy of management by a Board and Executive Committee, adopted by an increasing number of nonprofit organizations, allows for greater flexibility, adaptability, and nimbleness on the part of AMP to establish and easily modify its direction moving forward.

AMP’s membership includes four distinct subdivisions; Genetics, Hematopathology, Infectious Diseases, and Solid Tumors. Each subdivision represents a vital segment of AMP membership, reflecting the diversity, vitality, and wide range of specialties encompassed by AMP members.

“AMP has now matured as an organization and is ready to be governed differently than when it was founded,” said Iris Schrijver, MD, AMP President. “Over the course of several months, we studied many aspects of nonprofit governance, examined other organizations, and discussed how to create a model that best suits AMP. Our new governance structure will facilitate decision-making that is informed and strategic.”

The overarching catalyst for the changes to the AMP governance structure is the newly implemented strategic plan. The plan centers on five essential areas: advocacy, education, innovation and improved patient care, governance, and management. AMP’s policies, programs, resources and structure will all serve to support these elements of the strategic plan. For more information about the AMP Strategic Plan, visit http://www.amp.org.

ABOUT AMP:
The Association for Molecular Pathology (AMP) is an international medical professional association dedicated to the advancement, practice, and science of clinical molecular laboratory medicine and translational research based on the applications of molecular biology, genetics, and genomics. For more information, please visit http://www.amp.org/about/strategic_plan.cfm.

Comment/Share

View original post here:
New Governance Structure Approved by AMP Membership

Ask Keri Glassman: Diet, Nutrition & Health Questions!

Nutritionist Keri Glassman is joining Access' Healthy Hollywood team! Keri, who regularly shares her expert wellness advice on Access Hollywood Live , will now be answering your nutrition, diet & health questions.

Want to know which foods to use to slim down fast? Or, how to curb cravings? Ask Keri anything!

PLAY IT NOW: Access Hollywood Live: Richard Simmons Whips Billy Bush & Kit Hoover Into Shape!

Post your question on the Access Hollywood Live Facebook page, and we will choose one great question a week to be answered Thursdays in our Healthy Hollywood column. Plus, Keri might even answer your question live on the air during her Access Hollywood Live segments (airing every other Thursday, beginning Feb. 16)

CLICK HERE to submit your questions!

VIEW THE PHOTOS: On The Set: The Stars Visit Access Hollywood Live (Feb. 2012)

Plus, be sure to "Like" Keri Glassman's page on Facebook, HERE !

Copyright 2012 by NBC Universal, Inc. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Originally posted here:
Ask Keri Glassman: Diet, Nutrition & Health Questions!

CHOOSING A MICROSCOPE FOR SOIL MICROBIOLOGY by Dr. Elaine Ingham – Video

22-05-2011 12:19 Dr. Elaine Ingham gives advice on choosing a microscope for soil microbiology. Dr. Ingham is a world-renowned soil microbiologist who pioneered many of the currently used biological soil amendment techniques and pioneered the testing of soil microbial life as an indicator of soil and plant health. Dr. Ingham is the Chief Scientist at the Rodale Institute. She is the founder of the Sustainable Studies Institute and the Soil Foodweb Inc. soil testing labs. Dr. Ingham is the key author of the US Dept. of Agriculture's Soil Biology Primer. She has been the mentor of numerous soil scientists and practitioners of ecologically balanced landscape design, and has helped farmers all over the world to grow more resilient crops by understanding and improving their soil life.

See more here:
CHOOSING A MICROSCOPE FOR SOIL MICROBIOLOGY by Dr. Elaine Ingham - Video

New Study Suggests an Unconventional Approach May Help Boomers Prolong Retirement Savings

SAN DIEGO, CA--(Marketwire -02/06/12)- Brandes Investment Partners today released a new study by the Brandes Institute suggesting ways for investors to improve their financial prospects in retirement, including reducing the risk of outliving their assets ("money death"). The baby boom generation is now moving towards retirement age while longevity estimates suggest that their retirement may last much longer than expected. The study suggests that many of America's baby boomers could increase their retirement assets at advanced ages by maintaining a larger portion of their portfolios in higher-potential investments such as equities (rather than re-allocating prematurely into fixed income) and managing the risk of money death by investing a modest portion of their portfolio in longevity insurance. The study comes on the heels of the U.S. Treasury's plan to make it easier for defined contribution plans and IRAs to offer annuity options.

"Retirees in good health have a risk of outliving their assets regardless of their investment strategy. Our study suggests they may do better by aiming for superior long-term returns in their investment portfolios and dealing with money death risk separately," said Barry Gillman, Research Director, Brandes Institute Advisory Board. "This contradicts the conventional wisdom, which tells people to play it safe when they retire by moving a large portion of their portfolio to bonds.

"One problem with the conventional approach is that about 60% of the money distributed from typical retirement accounts should come from investment returns earned after retirement. Today's historically low yields are just not providing the returns retirees will likely need to sustain them.

"Until now, this approach has not been widely understood or used even by the healthy and wealthy individual investors who stand to benefit from it most. With the Treasury's new initiative to tear down some of the barriers to investing retirement savings in annuities, this could also become a practical solution for many participants with 401(k) and IRA savings."

The study cites evidence generated by the Brandes Retirement Simulator, a proprietary online model that projects a range of long-term asset outcomes based on an individual's personal finances and expected lifespan, as well as portfolio allocations and investment assumptions, and the use of longevity insurance. The full study is available on the firm's website at http://www.brandes.com/institute. Access to the Brandes Retirement Simulator will soon be available on the firm's website at no cost to retirees and advisors who can customize the inputs and integrate it into their retirement planning.

About Brandes

Brandes Investment Partners is a global investment advisory firm based in San Diego and along with its affiliates, manages more than $32 billion of assets as of December 31, 2011, for institutional and private clients worldwide. Since its inception in 1974, Brandes has applied the value investing approach to security selection pioneered by Benjamin Graham. Among the first investment firms to bring a global perspective to value investing, Brandes manages a variety of investment strategies.

Brandes Investment Partners, L.P. is a U.S. registered investment adviser. Brandes does not sell or endorse any insurance policy. More information can be found at http://www.brandes.com.

See the article here:
New Study Suggests an Unconventional Approach May Help Boomers Prolong Retirement Savings

James A. Shapiro: Purposeful, Targeted Genetic Engineering in Immune System Evolution

Your life depends on purposeful, targeted changes to cellular DNA. Although conventional thinking says directed DNA changes are impossible, the truth is that you could not survive without them. Your immune system needs to engineer certain DNA sequences in just the right way to function properly.

Today's blog is a tale of how cells engineer their DNA molecules for a specific purpose. It also illustrates how an evolutionary process works within the human body.

Your immune system has to anticipate and inactivate unknown invaders. Living organisms deal with unpredictable events by evolving. They change to adapt to new circumstances. Variation comes from their capacity for self-modification. Cells have many molecular mechanisms that read, write, and reorganize the information in their genomes, the DNA molecules used for data storage.

The adaptive immune system executes basic evolutionary principles in real time. It has to recognize and combat unknown (and utterly unpredictable) invaders. Immune system cells have to produce antibody molecules that can bind to any possible molecular structure.

How do cells with finite DNA, and finite coding capacity, produce a virtually infinite variety of antibodies? The answer is that certain immune cells (B cells) become rapid evolution factories. They generate antibodies with effectively limitless diversity while preserving molecular structures needed to interact with other parts of the immune system.

Immune cells achieve both diversity and regularity in antibody structures. They accomplish this by a targeted yet flexible process of natural genetic engineering: they cut and splice DNA.

Diversity is strictly limited to a special part of the antibody molecules: a "variable" region encoded by engineered DNA. DNA encoding the "constant" region does not change in the same way. The diversity-generating process is called "VDJ recombination" because it involves cutting and splicing together different "variable" (V), "diversity" (D) and "joining" (J) coding segments. Immune cells do this by cutting DNA at defined "recombination signal sequences." There are hundreds of V segments, about a few dozen D segments, and ten J segments. The various combinations of different spliced segments makes for a tremendous amount of diversity.

Antibodies contain two paired protein chains: a longer heavy chain and a shorter light chain. The heavy chain variable coding region forms by splicing V, D, and J segments together. The light chain variable coding region forms by joining V and J segments together. There are at least 10,000 VDJ combinations and 1,000 VJ combinations. Altogether, over 10,000,000 different heavy + light chain antibodies are possible through "combinatorial diversity."

Not bad... but not good enough.

VDJ recombination generates additional diversity. Although cutting the V, D, and J segments is precise, immune cells join each pair of cleaved DNA segments at about a dozen different positions. Connection between the same two segments can have about 30 to 35 possible different sequence outcomes. This "junctional diversity" adds over 1,000 possible antibody combinations.

In addition, heavy chain D segment joining has another virtually unlimited source of variability. Immune cells have an enzyme that attaches unique new DNA sequences to either end of the D segment. These are not encoded anywhere in the genome. Such so-called "N region" sequences can add over 1,000 new variations to each existing VDJ combination.

So the total possible genetically engineered antibody diversity is something above 10,000,000 X 1,000 X 1,000 = 10,000,000,000,000 combinations. This extraordinary number appears to be large enough to generate antibodies that can protect you from virtually any invader, whatever its molecular structure may be.

The immune system is itself a rapid evolutionary process, replacing one set of immune specificities with another. The right antibody-producing cells multiply when an invader enters the body. Antibodies sit on the surface of cells that made them. When a particular variable region binds an invader, that event sends a signal inside the cell to begin dividing.

Dividing immune cells are called "activated B cells," which proliferate into distinct populations. Because the descendants of a single activated B cell share the same engineered variable region coding sequences, they produce even more invader-recognizing antibodies. By binding, these antibodies signal the rest of the immune system to begin eliminating the invaders. This is the front-line "primary" adaptive immune response.

In a future blog, I'll explain ongoing natural genetic engineering as activated immune cells mature in the "secondary" response. It is no less amazing. For now, let's draw three conclusions from the initial rapid evolution system. We see that:

Evolution has produced a system that engineers DNA with a specific purpose: encoding proteins that bind to unpredictable invaders and signal the immune system to make more antibodies and eliminate the invaders. Precise targeting of DNA cutting to variable region-coding segments allows the basic antibody structure to stay the same. At the same time, its recognition/binding capacity changes. Your B cells are able to combine several different kinds of DNA biochemistry into a functional engineering process: 1) cutting the V, D and J segments; 2) joining the cleaved segments; and 3) synthesizing and inserting the N region sequences.

In the immune system, "purposeful" and "having a predestined outcome" are far from the same thing. Your immune system follows a regular process, but the end result is not fixed in advance. This is an important lesson to keep in mind as we witness ongoing public debates over evolutionary DNA change.

In biology, the alternative to randomness is not necessarily strict determinism. If the cells of the immune system can use well-defined natural genetic engineering processes to make change when change is needed, there is a scientific basis for saying that germ-line cells might do the same in the course of evolution.

 

Read more from the original source:
James A. Shapiro: Purposeful, Targeted Genetic Engineering in Immune System Evolution

Group: DNA of man convicted of rape does not match attacker

The DNA of a man convicted of raping a College of William & Mary student in 1978 does not match that of her attacker, a University of Virginia School of Law program announced Monday.

The Innocence Project is working to have the conviction of Bennett Barbour, 56, of Williamsburg, overturned, according to a news release.

Barbour was found guilty of the rape based on the victim’s eyewitness identification, even though her previous description of her attacker was different, the release said.

He was sentenced to 18 years, but paroled after serving five years because other evidence came to light casting doubt on his conviction, according to the Innocence Project. His blood type was different than the alleged perpetrator’s, according to the release.

Barbour’s DNA sample is among roughly 1,000 from crimes dating back to the 1970s that then-Virginia Gov. Mark R. Warner ordered tested.

The Innocence Project said the DNA sample in Barbour’s case matched that of a convicted sex offender, who is currently out on parole. The state has not revealed the man’s identity.

The Virginia Attorney General's Office has ordered a second DNA test to verify that Barbour’s DNA does not match the attacker’s. If the second test verifies the original result, the Innocence Project Clinic said it will file a petition for a writ of actual innocence with the Supreme Court of Virginia requesting that Barbour's conviction be overturned.

Read more:
Group: DNA of man convicted of rape does not match attacker

Posted in DNA

New DNA Product Simplifies Science and Gives Consumers Affordable Access to People and Places Their DNA Most Closely …

ConnectMyDNA™ announced today that it has nationally launched its revolutionary new DNA testing product for the consumer market, offering secure and affordable genetic testing to people all over the world. ConnectMyDNA™ is the first DNA testing product which provides results in an engaging visual and social environment. DNA Diagnostics Center (DDC), a world leader in DNA testing, is the parent company of ConnectMyDNA™.

FAIRFIELD, Ohio (PRWEB) February 06, 2012

ConnectMyDNA™ announced today that it has nationally launched its revolutionary new DNA testing product for the consumer market, offering secure and affordable genetic testing to people all over the world. ConnectMyDNA™ is the first DNA testing product which provides results in an engaging visual and social environment. DNA Diagnostics Center (DDC), a world leader in DNA testing, is the parent company of ConnectMyDNA™.

ConnectMyDNA™ features the Gene Ring™, which is a revolutionary new concept in DNA technology that merges modern art with cutting edge science. Not only is it an eye-catching symbolization of a person’s unique genetic makeup, it's also a scientifically accurate tool that allows a person to visually compare their DNA profile to friends, families and population groups around the world. Using 13 specific markers in a person’s DNA, the same used by forensic sciences for identification purposes, ConnectMyDNA™ matches these markers to DNA of population groups in over 60 countries to determine the ten country populations that a person most closely matches. No two Gene Rings™ are alike, but some are more connected than others and discovering those connections is what ConnectMyDNA™ is all about.

“ConnectMyDNA™ initially launched through HomeRun.com as a test to determine the sustainability of the product and demographics of its users. Within days of launching, ConnectMyDNA™ sold over 1000 units, making it one of the top selling products for HomeRun.com. This is a product which is simple to use, affordable and engaging for everyone. Customers receive an easy-to-use DNA Collection Kit containing the information, instructions, and tools they need to collect a sample of their DNA with a simple cheek swab. The next step is to send the package back to ConnectMyDNA™ in a prepaid envelope and await results. When a customer receives their results, they can securely view their Gene Ring™, a visual illustration of their genetic makeup, online,” said Peter Vitulli, DDC President and CEO.

Vitulli added, “The Gene Ring™ doesn’t contain any genetic information regarding the person’s health or genetic predisposition and is generated using a proprietary technology stored in a secure database so that genetic information can’t be decoded. ConnectMyDNA™ is not intended to be an ancestry test or product – instead it is designed to be a fun, educational product that introduces people to the world of DNA through the Gene Ring™ and population matches. Although the test is based on science, the results can be entertaining as well as enlightening and are an exciting way for people around the world to compare their genetic similarities to their family, friends, and others.”

There are many social features available through ConnectMyDNA™. Customers receive their results online and are offered a variety of ways to view their genetic data, learn about the people and places that their DNA most closely matches, and share their Gene Ring™ with their friends on their favorite social networks.

About DNA Diagnostics Center (DDC), Parent Company of ConnectMyDNA™

DDC is one of the largest DNA testing companies in the world. Founded 17 years ago, DDC offers comprehensive DNA testing services for paternity and other family relationships, forensics, cell line authentication, and ancestry. DDC receives more than 800,000 consumer calls each year, and has performed over 1 million DNA tests since the company was established. The Company is known for its groundbreaking technologies, including an exclusive license for the most innovative and accurate non-invasive prenatal paternity test using SNP (single-nucleotide polymorphism) Microarray Technology, which only requires a simple blood draw from the mother and alleged father. DDC’s unique Dual Process™ ensures all professionally collected DNA samples are independently tested twice producing legal results of unmatched quality and reliability. DDC is recognized through a number of accreditations nationally and internationally achieving perfect ratings in its past 16 inspections including those performed by the American Association of Blood Banks (AABB) and the College of American Pathologists (CAP). DDC is also accredited by ACLASS to meet the standards of ISO 17025 and the American Society of Crime Laboratory Directors Laboratory Accreditation Board International and follows the DNA Advisory Board (DAB) guidelines, which attests to DDC’s superior forensic testing service. For more information: http://www.dnacenter.com or 1-800-362-2368.

###

Jan Strode
CEO Advisors
619-890-4040
Email Information

Read the original here:
New DNA Product Simplifies Science and Gives Consumers Affordable Access to People and Places Their DNA Most Closely ...

Posted in DNA

Friendswood ISD announces science fair winners

Posted: Monday, February 6, 2012 10:43 am | Updated: 10:47 am, Mon Feb 6, 2012.

The winners of the Friendswood High School Science Fair, held Jan. 25, advanced to the Galveston County Science and Engineering Fair held on Saturday, Feb. 4 and the Science and Engineering Fair of Houston at the George R. Brown Convention Center on March 1-3.

In Behavioral Science, Silva Shanika placed first with Katherine Harclerode in second and Garrett Benson in third place.

In Botany, Janae Bonnen placed first with Matthew Laitkep in second.

In Chemistry, Cassie Nagle tied with Kelly Janak for first place with Nicole Bluth in second place.

FHS students won four places in Computer Sciences. Roma Pradhan won first with Chandika Silva in second, Rachel Goeken in third and Tim Crews in fourth place.

In Energy and Transportation category, Caroline Landon was awarded first place, David Bordelon second, and Michael Laitkep third place.

The engineering category had several ties. While Audrey McKee won first place, Daniel Bellian and Ben Burkick tied for second place. Olivia Williams and Carl Edeen tied for third place. Julie Rogers placed fourth with Brooks Pettit in fifth place.

In Environmental Science, two ties were announced. Taylor Cubbage tied for first place with Julia Conger and Rachel Truong and Lauren Peplinski tied for second place. Amy Peryam placed third.

The math winner was Daniel Bradley who placed second.

In the category of Medicine/Health, Nikita Gupta placed first, Heidi Henricks second, Owen O’Neill in third and Ian Bukowski in fourth place.

In Microbiology, students won first through fifth places. Emelie Nelson was named first place with Pahno Georgeton second, Karan Jerath third, Derek Abraham fourth and Dylan Dickens fifth.

James McCullough was first with Derek Janak in second place in Physics category.

Ninth Grade Biological Science winners were Taylor Cubbage with first place and Emelie Nelson in second.

Ninth Grade Physical Science winners included Audrey McKee in first place and Kelly Janak in second place.

The Senior Division Biological Science winners include Janae Bonnen in first place with Julia Conger in second.

The Senior Division Physical Science winners are Jamie McCullough in first place. Roma Pradhan and Caroline Landon tied for second place.

FHS science teacher Rebecca Clark chaired the Science Fair.

Read the original:
Friendswood ISD announces science fair winners

Proteonomix, Inc. (PROT) Brings in Additional Leadership in Order to Expand Management

MOUNTAINSIDE, NJ--(Marketwire -02/06/12)- PROTEONOMIX, INC. (OTC.BB: PROT.OB - News), a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, announced today that it has brought in new executive management as part of a new staffing effort to round out its executive committee.

Steven Byle joins Proteonomix as Chief Technology Officer. Mr. Byle brings over twenty years experience in technology development, business, development and technology licensing to the company. He joins us from his most recent position at Dockwise, where he was VP Technology and CTO, for this company having revenue exceeding $500M. Mr. Byle has been a member of the board and significant investor in Proteonomix for more than three years.

Mr. Byle shall assist with business development, licensing, business agreements, and the intellectual property portfolio. He shall further take on increasing duties in the operation of the day to day business. This will allow the CEO, Michael Cohen to increasingly focus his efforts towards the laboratory as Proteonomix enters human trials and expands its research efforts.

Mr. Byle states, "I have been waiting for the right moment when my business experience in business development and negotiation could add real value to Proteonomix. I have assisted in supporting the company financially for more than three years, but I feel that the company has now turned the page onto a new chapter and my efforts will best serve the company directly. It will be my foremost focus to secure opportunities for Proteonomix technology that involve significant capital investment -- as recognition of the value I perceive in this company -- and that also involve near term and sustained revenues going forward."

Mr. Byle continued, "I feel that the impending human trials for UMK-121 for liver disease are just the start for the company. There is a series of technologies we are developing which cover major health issues such as heart disease and possibly even diabetes, not to mention the line of cosmeceuticals. There are no guarantees of success and there is much to do, but I believe that the company now has a great start."

Also joining the Proteonomix family is Ms. Jaci Mandil, coming on board to lead the subsidiary Proteoderm, as CEO. Ms. Mandil brings thirteen years of experience as an executive in sales and marketing for several companies, including a fortune 500 company. Ms. Mandil's first task is to bring in funding to begin the production of the Proteoderm line. Included in the initial launch plans is to start distribution through a physician network and to seek overseas distribution partners.

About Proteonomix, Inc.:
Proteonomix is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives. The Proteonomix Family of companies includes Proteoderm, StromaCel, PRTMI and THOR Biopharma. Proteoderm, Inc. is a wholly owned subsidiary that has developed an anti-aging line of skin care products. StromaCel, Inc. develops therapeutic modalities for the treatment of Cardiovascular Disease (CVD). Proteonomix Regenerative Translational Medicine Institute, Inc. ("PRTMI") intends to focus on the translation of promising research in stem cell biology and cellular therapy to clinical applications of regenerative medicine. Proteonomix intends to create and dedicate a subsidiary to each of its technologies. Please also visit http://www.proteonomix.com/, http://www.proteoderm.com/, http://www.otcqb.com/ and http://www.sec.gov/.

Forward-looking statements:

Certain statements contained herein are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). Proteonomix, Inc. cautions that statements made in this press release constitute forward-looking statements and makes no guarantee of future performance. Actual results or developments may differ materially from projections. Forward-looking statements are based on estimates and opinions of management at the time statements are made.

Originally posted here:
Proteonomix, Inc. (PROT) Brings in Additional Leadership in Order to Expand Management

$30 million donation from Boris family will help McMaster turn stem cell research into therapy

McMaster University is on its way to moving stem cell research “from the bench to the bedside” thanks to a $30 million boost from a local family.

The Marta and Owen Boris Foundation made the large donation to establish a human stem cell therapy centre and a unique clinic for patients with complex health conditions.

Owen, the founder of Mountain Cablevision, was in talks with McMaster about investing in their work before he died last April. His children and wife contacted the university a month later and carried out his vision, firming up their commitment last November.

The Boris Family Centre in Human Stem Cell Therapies will be developed as part of the McMaster Stem Cell and Cancer Research Institute using $24 million of the funds.

“It’s getting over that chasm from the bench to the bedside that this (donation) is going to allow us to do,” the institute’s scientific director Dr. Mick Bhatia said.

The centre will give scientists the resources to focus on converting McMaster’s breakthroughs — such as the ability to make blood or types of neural cells with stem cells — into clinical applications through investigative trials, Bhatia said.

“In the absence of this donation, I think we would not be in the position to move our discoveries forward,” he said. “This is a huge leg-up. I’m hoping what it’s really going to do is have a ripple effect to change the way McMaster views translating basic science.”

They plan on developing human stem cell therapies targeting leukemia and possibly neural diseases such as Alzheimer’s and Parkinson’s, said Dr. John Kelton, dean and vice-president of the faculty of health sciences.

The remaining $6 million will go toward building a clinic in partnership with Hamilton Health Sciences (HHS) where patients with complex health issues can see specialists and undergo tests in one visit.

This was a result of his parents’ frustrating experiences in recent years with co-ordinating specialists and getting diagnostic testing done in Canada, said Owen’s son, Les Boris.

They ended up going to Mayo Clinic in Rochester, Minn., where they had a case manager who co-ordinated their appointments with specialists and made sure testing was done in-house, he said. “They like the idea of a one-stop shop … (My father) said: ‘This is the kind of model we need here in this country.’”

Kelton said the medical clinic, which will be built in the university’s medical centre, will look for rapid turnaround times and avoid duplications of lab tests. McMaster and HHS will also evaluate the clinic’s success and keep an electronic medical record that patients could access, he said.

Kelton and Owen met three years ago and had their last meeting about the projects three days before the philanthropist died.

Owen had worked on the Avro Arrow and was frustrated with Canada’s lost opportunity of making jet planes for the world, Kelton said.

“He said, ‘Tell me about some opportunities (that) – if we invested in it – could make Hamilton and McMaster world-class. What are some of the areas like an Avro Arrow?’”

The funds for the human stem cell therapy centre will go toward hiring a research chair in blood stem cells and a research chair in neural stems cells, setting up several fellowships and technician positions, and building the facility.

Bhatia says they hope to bring in new scientists and fellows by the early summer.

The Boris family previously donated $6 million to addiction research at St. Joseph’s Healthcare for its new mental health hospital being built on the Mountain and another $5 million for the da Vinci SI Surgical Robotic System.

“We’re very appreciative that we’re in a position to be doing something for the community,” Les said. “And it was the community that put us in the position to do this.

dawong@thespec.com

905-526-2468 | @WongatTheSpec

Read more here:
$30 million donation from Boris family will help McMaster turn stem cell research into therapy

DNA, skull may solve Utah flash flood mystery

Southern Utah authorities are hoping to solve a 50-year-old mystery over a deadly flash flood with the help of a human skull fragment found in the Virgin River several years ago.

The September 1961 flood caught a Boy Scout group and others by surprise and killed five people in the river's Zion National Park Narrows section.

Springdale Police Chief Kurt Wright told The Spectrum of St. George ( http://bit.ly/ApAyZf) that only three of the bodies were recovered, and he thinks the skull fragment holds the answer to what became of one of two 17-year-old Salt Lake City boys whose bodies were never found.

The parents of Eagle Scouts Alvin Nelson and Frank Johnson have since died, but Wright was able to track down a living sibling for each and received DNA samples from them last week. He hopes the samples will identify whether the skull was from one of the boys.

Wright said he became interested when he learned of a free program at the University of Texas that matches DNA to identify skeletal remains. The skull fragment and DNA samples now are on their way to Texas for examination.

Doralee Freebairn, 65, of Holladay, the sister of one of the boys, said she hopes the DNA samples bring closure.

"It's a tough thing. Without that body, you don't really believe that they're gone," she told The Spectrum. "My feeling's strong that it's my brother Alvin. But the DNA will tell."

Past searches failed to turn up the bodies of Nelson and his best friend, Johnson, who both attended East High School in Salt Lake City. The boys were doing what they loved and enjoying the outdoors before the flood struck, Freebairn said.

"One of the girls who survived said they looked up and heard this horrible sound coming through the canyon," Freebairn said. "It was a beautiful day before the storm moved in."

The bodies of Scoutmaster Walter Scott of Murray; Steven Florence, 13, of Park City; and Paul Nicholes, 17, of Salt Lake City, were recovered.

___

Information from: The Spectrum, http://www.thespectrum.com

See more here:
DNA, skull may solve Utah flash flood mystery

Posted in DNA

Washington considers collecting DNA upon arrest in serious crime

Originally published February 5, 2012 at 8:21 PM | Page modified February 5, 2012 at 8:22 PM

Anthony Dias is the poster boy for why police and prosecutors hope Washington will join a growing number of states that require people to give DNA samples as soon as they're arrested in a serious crime, rather than when they're convicted.

In 2005, Dias was released on bail while facing a felony hit-and-run charge in Pierce County. Before the year was up, he went on to commit crimes — including half a dozen rapes — against 19 more people. If he had given a DNA sample after his hit-and-run arrest, detectives could have caught him after the first rape — not the last.

"By the time he committed his next rape crime, he could have been identified, arrested and taken off the streets," Charisa Nicholas, who was tied up and forced to watch as her roommate was raped, told lawmakers recently. "My case would have been the first case prevented."

Nevertheless, the rush to expand DNA's use in criminal investigations worries privacy advocates, and courts around the country have disagreed about whether such laws violate the Fourth Amendment to the U.S. Constitution, which protects people from unreasonable searches and seizures.

Many judges have ruled that routinely collecting DNA from convicts is OK because, among other reasons, committing a serious crime reduces their expectation of privacy. It's not clear that reasoning would extend to people who have not been convicted and are presumed innocent.

"The way judges come out depends in a sense on how much trust they have in the government," says Penn State Law School professor D.H. Kaye, who tracks the issue. "Some judges say, 'What's the big deal? It's like a fingerprint.' But DNA samples contain a lot of information, and other judges say that sooner or later somebody is going to abuse the system."

Under bills before the Legislature, the state would collect DNA from people when they're arrested for nearly all felonies or for violating a domestic-violence protection order. Once a judicial officer finds that the arrest was supported by probable cause, the State Patrol crime lab could test the DNA to create a profile and enter it in a nationwide database. The cost of the measure — more than $400,000 a year — would be covered by money from traffic tickets.

Those exonerated or not charged could petition to have the crime lab destroy their sample and profile. The lab would be obligated to do so, but could run a check on the profile first.

About half the states and the federal government have similar laws.

The 3rd U.S. Circuit Court of Appeals in Philadelphia, the highest federal court to rule on the issue so far, closely upheld the federal law 8-6 last summer in a case that could be headed for the Supreme Court. The majority found that although crime labs typically maintain the actual DNA samples, the profiles entered into the national database make up only a small portion of the information available in the sample. There's no indication that the government has any intent to use the full samples, judges said.

The judges reasoned that the government has a right to confirm the identities of the people it arrests, and there are two parts to someone's identity: who they are, and what they've done. Using the DNA profile to see if arrestees have committed other crimes is a part of the government's interest in their identities, the judges said.

The dissent argued that the government doesn't need the DNA profile to identify arrestees. Officials want to be able to conduct an intrusive search of a person's body — taking their DNA — without a warrant and without suspicion, in hopes of finding evidence unrelated to why the person was arrested.

"We do not view a finding of probable cause for one crime as sufficient justification to engage in warrantless searches of arrestees' or pretrial detainees' homes for evidence of other crimes," the dissent noted.

That's one of the analyses offered by Doug Klunder, privacy counsel at the American Civil Liberties Union of Washington.

"It's collecting really sensitive information about an individual without there being reason to suspect that person of a crime," he says. "There are many ways that law enforcement could collect information that would help solve crimes. They could rifle through my house every day and maybe they'll find it, but we don't allow that without a warrant. Certainly going into my body is as intrusive as going into my house."

Read the original:
Washington considers collecting DNA upon arrest in serious crime

Posted in DNA